Your browser doesn't support javascript.
loading
Prevention and treatment of anticipatory chemotherapy-induced nausea and vomiting in pediatric cancer patients and hematopoietic stem cell recipients: Clinical practice guideline update.
Patel, Priya; Robinson, Paula D; Devine, Katie A; Positano, Karyn; Cohen, Marie; Gibson, Paul; Holdsworth, Mark; Phillips, Robert; Spinelli, Daniela; Thackray, Jennifer; van de Wetering, Marianne; Woods, Deborah; Cabral, Sandra; Sung, Lillian; Dupuis, L Lee.
Affiliation
  • Patel P; Pediatric Oncology Group of Ontario, Toronto, Ontario, Canada.
  • Robinson PD; Pediatric Oncology Group of Ontario, Toronto, Ontario, Canada.
  • Devine KA; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
  • Positano K; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Cohen M; Patient Representative.
  • Gibson P; Pediatric Oncology Group of Ontario, Toronto, Ontario, Canada.
  • Holdsworth M; Division of Haematology/Oncology, McMaster Children's Hospital, Hamilton, Ontario, Canada.
  • Phillips R; College of Pharmacy, University of New Mexico, Albuquerque, New Mexico, USA.
  • Spinelli D; Department of Haematology and Oncology, Leeds Teaching Hospital, NHS Trust, Leeds, UK.
  • Thackray J; Patient Representative.
  • van de Wetering M; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Woods D; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Cabral S; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Sung L; University of California, Davis Health, Pediatric Hematology/Oncology, Davis, California, USA.
  • Dupuis LL; Pediatric Oncology Group of Ontario, Toronto, Ontario, Canada.
Pediatr Blood Cancer ; 68(5): e28947, 2021 05.
Article in En | MEDLINE | ID: mdl-33686754
ABSTRACT
This 2021 clinical practice guideline update provides recommendations for preventing anticipatory chemotherapy-induced nausea and vomiting (CINV) in pediatric patients. Recommendations are based on systematic reviews that identified (1) if a history of acute or delayed CINV is a risk factor for anticipatory CINV, and (2) interventions for anticipatory CINV prevention and treatment. A strong recommendation to optimize acute and delayed CINV control in order to prevent anticipatory CINV is made. Conditional recommendations are made for hypnosis, systematic desensitization, relaxation techniques, and lorazepam for the secondary prevention of anticipatory CINV. No recommendation for the treatment of anticipatory CINV can be made.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vomiting, Anticipatory / Hematopoietic Stem Cell Transplantation / Nausea / Neoplasms / Antineoplastic Agents Type of study: Guideline / Prognostic_studies / Risk_factors_studies Limits: Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2021 Document type: Article Affiliation country: Canada
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vomiting, Anticipatory / Hematopoietic Stem Cell Transplantation / Nausea / Neoplasms / Antineoplastic Agents Type of study: Guideline / Prognostic_studies / Risk_factors_studies Limits: Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2021 Document type: Article Affiliation country: Canada